Skip to content

Home
Our research
Market
Press release
Reports
Plans
Partnering
About us

Menu

Home
Our research
Market
Press release
Reports
Plans
Partnering
About us

Bokslutskommuniké för 2015 publicerad

Bokslutskommuniké för perioden 2015-01-01 till 2015-12-31 är nu publicerad.

Contact us

Kristian Lykke Fick

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising novel and proprietary dermatological drug candidate FOL005. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved